Virginia

Virginia

5,209
Registered Patient Population
0%
of Total Population Represented by Patients
0
Total Medical Retail Locations Currently in Operation
N/A
Ratio of Patients to Retail Location

CBD treatment is legal in Virginia. Patients with intractable seizures may purchase and possess cannabis with 15 percent CBD or THCA and no more than 5 percent THC. This is the highest THC content limit amongst states with legalized cannabis access. In-state production and sales have been authorized.

Patient Rights and Civil Protection 47/100   
Arrest Protection 20/40
Affirmative Defense 15/15
Parental Rights Protections 0/10
DUI Protections 0/5
Employment Protections 0/5
Explicit Privacy Standards 7/7
Housing Protections 0/5
Does Not Create New Criminal Penalties for Patients 5/5
Organ Transplants 0/5
Reciprocity 0/3
Access to Medicine 44/100   
Allows Distribution Programs 13/40
– Allows Access to Dried Flowers 0/15
– Allows Delivery 0/5
– No Sales Tax or Reasonable Sales Tax 5/5
– Allows for a Reasonable Number of Dispensaries 3/5
– Does Not Require Vertical Integration 1/2
– Ownership/Employment Restrictions 2/2
– Provisions for Labor Standards 0/2
– Environmental Impact Regulations 0/2
– Choice of Dispensary Without Restrictions 2/2
Noncommercial Cultivation 0/20
– Personal Cultivation 0/15
– Collective Gardening 0/5
Explicit Right to Edibles/Concentrates/Other Forms 5/10
Does not Impose Bans or Limits on THC 7/10
Does not Impose Bans on CBD 9/10
Local Bans/Zoning 10/10
Comprehensive Qualifying Conditions 50/50
Adding New Conditions 10/10
– Law/Regulations Allow for New Conditions 5/5
– System Works for Adding New Conditions 5/5
Reasonable Access for Minors 6/10
Reasonable Caregiver Background Checks 2/4
Number of Caregivers 1/2
Patient/ Practitioner- Focused Task Force or Advisory Board 0/2
Reasonable Fees (Patients and Caregivers) 10/10
Allows Multiple-Year Registrations 0/2
Reasonable Physician Requirements 5/5
Does Not Classify Cannabis as a Medicine of Last Resort 3/5
Functionality 59/100   
Patients Able to Access Medicine at Dispensaries or by Cultivation 20/50
No Significant Administrative or Supply Problems 15/15
Patients Can Receive Legal Protections Within Reasonable Time Frame of Doctor's Recommendation 10/10
Reasonable Possession Limits 3/5
Reasonable Purchase Limits 3/5
Allows Patients to Medicate Where They Choose 3/5
Covered by Insurance/State Health Aid 0/3
Financial Hardship (Fee Waivers/Discount Medicine) 5/7
Consumer Safety and Provider Requirements 47.59/100   
Dispensing 13.34/25
Staff Training 4/5
Standard Operating Procedures 3/5
– Facility Sanitary Conditions 0/1.25
– Storage Protocols 1/1.25
– Reasonable Security Protocols 1/1.25
– Inventory Control 1/1.25
Recall Protocol and Adverse Event Reporting 1/5
Product Labeling 2.67/5
– Product Contents, Including Source Material Identification 1.67/1.67
– Allergens 0/1.67
– Potency/Compound Identification 1/1.67
Required Testing 2.67/5
– Active Compound Identification 1.67/1.67
– Contaminants 0/1.67
– Potency 1/1.67
Grow/Cultivation 9.09/25
Staff Training 0/5
Standard Operating Procedures 2.84/5
– Facility and Equipment Sanitary Conditions 0.71/0.71
– Workforce Safety Protocols 0/0.71
– Storage Protocols (Short-Term and Long-Term Storage) 0.71/0.71
– Reasonable Security Protocols 0.71/0.71
– Batch and Lot Tracking 0.71/0.71
– Disposal/Waste 0/0.71
– Water Management 0/0.71
Pesticide Guidance 3/5
– Pesticide Guidance 2/2.5
– Pesticide Labeling 1/2.5
Required Testing 2.25/5
– Active Ingredient Identification 1.25/1.25
– Contaminants 0/1.25
– Potency 1/1.25
– Sample Retention 0/1.25
Recall Protocol and Adverse Event Reporting 1/5
Manufacturing 12.67/25
Staff Training 4/5
Standard Operating Procedures 3/5
– Facility and Equipment Sanitary Conditions 1/1
– Workforce Safety Protocols 0/1
– Storage Protocols 1/1
– Reasonable Security Protocols 1/1
– Batch and Lot Tracking 0/1
Product Labeling 2.67/5
– Product Contents, Including Source Material Identification 1.67/1.67
– Allergens 0/1.67
– Potency and Compound Information 1/1.67
Required Testing 2/5
– Active Ingredient Identification 1/1
– Contaminants 0/1
– Potency 1/1
– Shelf Life Testing 0/1
– Sample Retention 0/1
Recall Protocol and Adverse Event Reporting 1/5
Laboratory Operations 12.49/25
Staff Training 2/5
Method Validation in Accordance with AHP Guidelines 0/5
Result Reporting 3/5
Independent or Third Party 5/5
Standard Operating Procedures and Protocols 2.49/5
– Equipment and Instrument Calibration 0/0.83
– Sample Tracking 0.83/0.83
– Facility and Equipment Sanitary Conditions 0.83/0.83
– Disposal/Waste 0/0.83
– Storage Protocols 0.83/0.83
– Workforce Safety Protocols 0/0.83
Covid Response 0/20   
Delivery Available? 0/6
Curbside Pickup Available? 0/2
Medical Cannabis Essential? 0/7
Telemedicine Available? 0/5
Excerpted from ASA's 2020 State of the States Report.

In This Section

Becoming a Caregiver, Producer, or Provider in Virginia

The law does not provide for legal protections to caregivers. SB 701 permits pharmaceutical processors who has obtained a permit from the Board of Pharmacy to manufacture CBD or THC-A.

Virginia Medical Marijuana Laws

HB1445 creates an affirmative legal defense for patients who use certain CBD or THC-A extracts with the written certification of a doctor.

Becoming a Patient in Virginia

HB 1251 creates an affirmative legal defense for patients using CBD or THC-A cannabis extracts which contain at least 15% CBD or THC-A and less than 5% THC by weight with a doctors written certification.

Recommending Cannabis in Virginia

In order to complete a written certification in Virginia, a physician must be licensed by the Board of Medicine. Doctors may recommend low THC cannabis oils for individuals with any condition if the doctor believes it will benefit the patient.

Virginia Advocacy

Find local ASA Chapters, Action Groups and Affiliates in Virginia and get involved in local campaigns.

The State of Medical Marijuana in Virginia

The State of Medical Marijuana in Virginia